Literature DB >> 9360548

Extraskeletal osteoclastomas responsive to dexamethasone treatment in Paget bone disease.

K Ziambaras1, W A Totty, S L Teitelbaum, M Dierkes, M P Whyte.   

Abstract

Giant cell tumors (GCTs) of bone, also called osteoclastomas, complicate Paget bone disease (PBD), though infrequently. Giant cell reparative granulomas (GCRGs), which are histologically similar to GCTs, also occur rarely in pagetic patients. A 45-yr-old black woman with neurofibromatosis, type I, and polyostotic PBD developed slowly-growing masses in the right posterior iliac and left upper parasacral regions. She had multiple cutaneous neurofibromas and café-au-lait spots. Serum alkaline phosphatase activity and urine hydroxyproline levels were elevated. Skeletal radiographs and bone scintigraphy showed changes of widespread PBD. Computerized tomography and magnetic resonance imaging (MRI) delineated masses in the right gluteal and the left lower lumbar paraspinal regions. Five additional smaller masses were found in the abdomen and in the pelvis. Biopsy of the right gluteal mass revealed a GCT. However, we found that this lesion had several histologic features distinct from those of giant cell reparative granulomas or GCT. In our patient's tumor, the huge polykaryons, like osteoclasts, expressed abundant tartrate-resistant acid phosphatase activity, whereas those of GCRG lack this enzyme. Although the polykaryons in conventional GCTs and GCTs in PBD express tartrate-resistant acid phosphatase activity, the location of these tumors in bone differs from the extraskeletal masses encountered in our patient. Furthermore, the larger size of the polykaryons and the greater number of nuclei in our patient's GCT differ from conventional GCTs, but not GCTs in PBD. Her extraskeletal osteoclastoma rapidly shrunk to one third its original size during 2 weeks of oral dexamethasone treatment. Significant clinical improvement lasted about 5 months before additional courses of dexamethasone therapy were necessary. Injections of synthetic salmon calcitonin alone did not affect the tumor's size. Thus, PBD can be complicated by extraskeletal tumors that seem to contain osteoclasts and are responsive to dexamethasone treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360548     DOI: 10.1210/jcem.82.11.4353

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Giant-cell-rich pseudotumour in Paget's disease.

Authors:  N M Gamage; T G Kashima; M A McNally; C L M H Gibbons; R Smith; S J Ostlere; N A Athanasou
Journal:  Skeletal Radiol       Date:  2012-12-29       Impact factor: 2.199

2.  Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Authors:  Joseph L Shaker
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

3.  Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

Authors:  Michael P Whyte; Katherine L Madson; Steven Mumm; William H McAlister; Deborah V Novack; Jo C Blair; Timothy R Helliwell; Marina Stolina; Laurence J Abernethy; Nicholas J Shaw
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

4.  Giant cell tumor in a case of Paget's disease of bone: an aggressive benign tumor exhibiting a quick response to an innovative therapeutic agent.

Authors:  Roberta Cosso; Vincenzo Nuzzo; Alfonso Zuccoli; Maria Luisa Brandi; Alberto Falchetti
Journal:  Clin Cases Miner Bone Metab       Date:  2010-05

5.  Infiltrating giant cell tumor in a case of Paget's disease of bone.

Authors:  Vincenzo Nuzzo; T Ferrara; Alfonso Zuccoli; Raffaella Brunetti-Pierri; Roberto De Rosa; Alberto Falchetti; R Franco; Nicola Brunetti-Pierri
Journal:  Arch Osteoporos       Date:  2009-08-06       Impact factor: 2.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.